Health Theorem publishes evidence-first health science explanations for general readers. Our editorial policy is designed to make peptide biology, metabolic research, GLP-1 and related incretin science, body composition, appetite regulation, safety, and clinical evidence easier to understand—without overstating what the research can establish.
Our evidence standards
Published research and primary scientific or health authorities form the backbone of our coverage. Depending on the question, we prioritize peer-reviewed original studies, systematic reviews and meta-analyses, clinical-trial records and protocols, official prescribing information, and materials from authorities such as the FDA, EMA, NIH, NIDDK, and CDC.
Sponsor announcements can be useful for current drug-development updates when peer-reviewed findings are not yet available. We identify those results as sponsor-reported. Social media, forums, influencer posts, vendor blogs, and personal anecdotes may help identify questions worth examining, but they are not sufficient support for clinical claims.
How we interpret health research
Not all evidence answers the same question. We distinguish among biochemical or cell research, animal studies, observational human evidence, Phase 1 through Phase 3 trials, approved-use evidence, and real-world or post-marketing data. A plausible biological mechanism is not proof that an intervention is safe or effective in people.
When discussing clinical results, we aim to explain who was studied, what the comparison was, how long the study lasted, which outcome was measured, and the limitation most likely to affect interpretation. We treat cross-trial comparisons as indirect unless compounds were tested in a genuine head-to-head study. When relevant, we also explain the difference between relative and absolute effects.
Product and regulatory distinctions
Health Theorem keeps endogenous peptide biology separate from approved prescription medicines, investigational drug candidates, compounded products, supplements or cosmetics, and research-use-only materials. A shared molecule name does not establish equivalent formulation, quality, intended use, approval status, or human evidence.
We verify approval status, indications, warnings, labels, trial status, sponsor status, and availability whenever those details matter to an article. Contextual or commercial sources are not used as evidence of human safety, efficacy, approval, or appropriate treatment. Any material commercial relationship is disclosed when it matters to readers.
Medical boundaries and corrections
Health Theorem provides education, not diagnosis or individualized medical care. We do not provide personalized treatment selection, dosing, injection or reconstitution instructions, purchasing guidance, adverse-effect self-management instructions, or directions for using research-use-only materials in humans.
Our aim is to help readers understand how seriously to take a health claim, what the evidence does and does not show, and what uncertainty remains. For foundational context, readers can start with our plain-English guide to peptides or review how to assess peptide safety claims.
We welcome questions, feedback, and correction requests through the contact page. We review reported concerns against appropriate evidence and update published coverage when a material factual or interpretive correction is warranted.